Legal Representation
Attorney
Michael W. Piper
USPTO Deadlines 4 active 4 overdue
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
OFFICE ACTION
Non-Final Action Mailed |
CNRT | Oct 29, 2024 | 251 days overdue | Critical | Until Jan 29, 2025 |
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | Oct 29, 2024 | 251 days overdue | Critical | Until Jan 29, 2025 |
OFFICE ACTION
Non-Final Action Mailed |
CNRT | May 20, 2025 | 48 days overdue | Critical | Until Aug 20, 2025 |
OFFICE ACTION
Non-Final Action E-Mailed |
GNRT | May 20, 2025 | 48 days overdue | Critical | Until Aug 20, 2025 |
Application History
20 eventsDate | Code | Type | Description |
---|---|---|---|
May 20, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
May 20, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Feb 20, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED |
Feb 20, 2025 | IUAA | P | USE AMENDMENT ACCEPTED |
Feb 20, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Feb 20, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jan 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 29, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 29, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jan 24, 2025 | AUPC | I | AMENDMENT TO USE PROCESSING COMPLETE |
Jan 24, 2025 | IUAF | S | USE AMENDMENT FILED |
Jan 24, 2025 | EAAU | I | TEAS AMENDMENT OF USE RECEIVED |
Oct 29, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Oct 29, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Jul 29, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jul 29, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jul 29, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 24, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
Apr 5, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Dec 22, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Nutraceuticals for use as a dietary supplement; Nutritional supplements
First Use Anywhere:
19990000
First Use in Commerce:
19990000
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
TECHNOLOGY